MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 74 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $17,626,000 | -6.9% | 4,247,163 | -6.2% | 0.02% | -10.5% |
Q1 2019 | $18,924,000 | +44.8% | 4,527,325 | -0.6% | 0.02% | +26.7% |
Q4 2018 | $13,072,000 | -31.3% | 4,554,759 | +139.4% | 0.02% | -16.7% |
Q3 2018 | $19,025,000 | -2.4% | 1,902,523 | -31.0% | 0.02% | -5.3% |
Q2 2018 | $19,495,000 | +86.6% | 2,757,356 | +0.8% | 0.02% | +90.0% |
Q1 2018 | $10,450,000 | -52.5% | 2,735,623 | +1.4% | 0.01% | -54.5% |
Q4 2017 | $22,004,000 | +133.3% | 2,696,553 | +67.8% | 0.02% | +120.0% |
Q3 2017 | $9,432,000 | +748.2% | 1,606,733 | +98.0% | 0.01% | +900.0% |
Q2 2017 | $1,112,000 | +61.2% | 811,665 | +108.1% | 0.00% | 0.0% |
Q1 2017 | $690,000 | – | 390,065 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management III, LLC | 5,016,164 | $10,835,000 | 2.15% |
Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,836,000 | 1.91% |
Asymmetry Capital Management, L.P. | 354,853 | $766,000 | 1.37% |
Lion Point Capital, LP | 6,374,740 | $13,769,000 | 1.28% |
Granite Point Capital Management, L.P. | 2,700,000 | $5,832,000 | 0.91% |
VHCP Management II, LLC | 1,486,676 | $3,211,000 | 0.85% |
Boxer Capital, LLC | 4,800,000 | $10,368,000 | 0.59% |
Avoro Capital Advisors LLC | 6,200,000 | $13,392,000 | 0.39% |
683 Capital Management, LLC | 925,382 | $1,999,000 | 0.23% |
Islet Management, LP | 875,000 | $1,890,000 | 0.18% |